90 results
Page 2 of 5
8-K
EX-4.2
haapyd3f9s3o vylfa8
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-4.1
tingj96 wx8r14l3s
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
jse2u7so3qur
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.2
5k2 uh1nq
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
8pbq6b9 w8gh
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
8-K
EX-4.2
y4xvtc
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.1
eol755f5zr156y47p xh
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.3
g8sx3dyxk9
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
s48 8zltc
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
mg6d0r5
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-4.1
moh k3ginkwt
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
katr7q6zdtubhqq w9u
3 Jun 22
Prospectus supplement for primary offering
9:45pm
8-K
EX-99.1
vpfceyy22
6 May 22
Regulation FD Disclosure
2:50pm
424B3
pbsn l5sx82zf
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
qiyfe b5j
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
lho gx4931zv
7 Apr 22
Prospectus supplement
4:46pm
S-3
deicctvjlrc6m1t697
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
1tih 8ym71fampgn
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm